Dynamic Advisor Solutions’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,129
Closed -$29.4K 956
2023
Q4
$29.4K Sell
2,129
-200
-9% -$2.04K ﹤0.01% 888
2023
Q3
$25.2K Buy
2,329
+300
+15% +$3.61K ﹤0.01% 837
2023
Q2
$26.2K Sell
2,029
-51
-2% -$690 ﹤0.01% 796
2023
Q1
$27.5K Sell
2,080
-200
-9% -$3.18K ﹤0.01% 739
2022
Q4
$34.2K Buy
2,280
+650
+40% +$5.96K ﹤0.01% 709
2022
Q3
$19K Sell
1,630
-500
-23% -$6.76K ﹤0.01% 678
2022
Q2
$24K Hold
2,130
﹤0.01% 694
2022
Q1
$64K Hold
2,130
﹤0.01% 712
2021
Q4
$56K Sell
2,130
-100
-4% -$3.02K ﹤0.01% 710
2021
Q3
$81K Buy
2,230
+100
+5% +$3.94K 0.01% 727
2021
Q2
$92K Buy
2,130
+400
+23% +$15.1K 0.01% 711
2021
Q1
$59K Sell
1,730
-300
-15% -$11.9K 0.01% 649
2020
Q4
$71K Sell
2,030
-157
-7% -$4.54K 0.01% 648
2020
Q3
$52K Buy
+2,187
New +$53.7K 0.01% 581

Other funds holding RIGL

Dynamic Advisor Solutions's RIGL Position: Q1 2024 in Review

Dynamic Advisor Solutions sold out of Rigel Pharmaceuticals (RIGL) in Q1 2024, closing a stake of 2,129 shares — an estimated $29.4K sold.

Dynamic Advisor Solutions first reported a position in RIGL in Q3 2020 and held it in 14 quarters. The position peaked at $92K in Q2 2021. 117 funds tracked by Wall St. Rank hold RIGL as of Q1 2024.

  • Dynamic Advisor Solutions reported no remaining Rigel Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Dynamic Advisor Solutions sold 2,129 Rigel Pharmaceuticals shares in Q1 2024, an estimated $29.4K.
  • Dynamic Advisor Solutions first reported a position in Rigel Pharmaceuticals in Q3 2020 and held it in 14 quarters.
  • Dynamic Advisor Solutions's Rigel Pharmaceuticals position peaked at $92K in Q2 2021.
  • 117 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2024.

Based on Dynamic Advisor Solutions's 13F filing for Q1 2024, filed 12 Apr 2024.